Alphabet Pours $1B into Anthropic
Google (NASDAQ:GOOGL) has agreed to a new investment of more than $1 billion in generative AI startup Anthropic, according to sources. The fresh funding builds on Google’s past investments of $2 billion in Anthropic and 10% ownership stake in the startup, as well as a large cloud contract between the two companies. Anthropic is most well known for its Claude AI chatbot.The agreement comes as Anthropic, one of the key players in Silicon Valley’s artificial intelligence arms race, is in late-stage talks to raise a funding round of $2 billion at a $60-billion valuation led by Lightspeed Venture Partners. In December, Anthropic’s revenue hit an annualized $1 billion, which was an increase of roughly 10x year over year, the source said. The company’s revenue comes primarily from enterprise sales.Financial Times was first to report Google’s investment.Anthropic, which has been backed heavily by Amazon (NASDAQ:AMZN), was founded by former OpenAI research executives. It launched Claude in March 2023, and like OpenAI’s ChatGPT and Google’s Gemini, Claude has exploded in popularity as businesses incorporate generative AI chatbots across sales, marketing and customer service functions. Google’s parent company, Alphabet, nosed ahead five cents early Thursday to $198.42.
Recent Posts

Romanian Inflation Ends Tumultuous Year in Politics Close to 10%

UK Boosts Support For Offshore Wind in Bumper Auction

Ireland Is Trying to Get Back on the Data Center Bandwagon

Notice Concerning Change of Representative Executive Officer

Polish Recycler Bets Millions on Europe’s Critical Metals Push

Blistering Metals Rally Sends Silver, Tin and Copper to Records

Wellington Management Appoints Alex Behm to Strengthen Secondaries Capabilities

TCS and AMD Announce Strategic Collaboration to Drive AI Adoption at Scale

New data reinforces Ipsen’s commitment to bringing solutions and addressing care gaps in neurological diseases at TOXINS

TOXINS 2026: Clinical Updates on Galderma’s Leading Neuromodulator Portfolio Further Reinforce Its Leadership in Injectable Aesthetics


